Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) remain a clinical challenge due to limited treatment options. Recently, cefiderocol, a novel siderophore cephalosporin, and sulbactam-durlobactam, a bactericidal β-lactam–β-lactamase inhibitor combination, have been appr...

Description complète

Détails bibliographiques

Auteurs principaux:	Arta Karruli, Antonella Migliaccio, Spyros Pournaras, Emanuele Durante-Mangoni, Raffaele Zarrilli
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-12-01
Collection:	Antibiotics
Sujets:	carbapenem-resistant <i>Acinetobacter baumannii</i> cefiderocol sulbactam-durlobactam antimicrobial susceptibility mechanisms of resistance antimicrobial therapy
Accès en ligne:	https://www.mdpi.com/2079-6382/12/12/1729
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!